Kivo Health vs Andson Biotech

Side-by-side comparison of AI visibility scores, market position, and capabilities

Andson Biotech leads in AI visibility (41 vs 35)
Kivo Health logo

Kivo Health

EmergingHealthcare

General

Durham NC YC W23 Medicare-covered at-home pulmonary rehab for 16M US COPD patients shipping Kivo Kit; $475K MassMutual/Samsung NEXT-backed competing with Propeller Health for virtual respiratory rehabilitation at the 3-5% treatment gap.

AI VisibilityBeta
Overall Score
D35
Category Rank
#1057 of 1158
AI Consensus
69%
Trend
up
Per Platform
ChatGPT
33
Perplexity
29
Gemini
26

About

Kivo Health is a Durham, North Carolina-based telehealth company — backed by Y Combinator (W23) with $475,000 raised from MassMutual Ventures, Samsung NEXT Ventures, Heuristic Capital, Quint Ventures, and SNR Ventures — providing Medicare-covered 8-week pulmonary rehabilitation programs to patients with chronic obstructive pulmonary disease (COPD), asthma, bronchitis, and other chronic lung conditions through an at-home telehealth delivery model that ships comprehensive Kivo Kits (containing an iPad pre-loaded with the Kivo platform and monitoring equipment) directly to patients' homes for virtual respiratory therapist sessions, structured exercise programs, and lung function monitoring. Founded in 2021 by founders with medical backgrounds and targeting the 16 million US patients with chronic lung conditions who represent $50 billion in annual healthcare spending.

Full profile
Andson Biotech logo

Andson Biotech

EmergingHealthcare

General

Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.

AI VisibilityBeta
Overall Score
C41
Category Rank
#220 of 1158
AI Consensus
62%
Trend
up
Per Platform
ChatGPT
49
Perplexity
36
Gemini
40

About

Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.

Full profile

AI Visibility Head-to-Head

35
Overall Score
41
#1057
Category Rank
#220
69
AI Consensus
62
up
Trend
up
33
ChatGPT
49
29
Perplexity
36
26
Gemini
40
26
Claude
41
38
Grok
51

Key Details

Category
General
General
Tier
Emerging
Emerging
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.